The Hair Loss Encyclopedia
Setipiprant is an investigational oral medication that acts as a selective antagonist of the prostaglandin D2 receptor (DP2), which is implicated in hair loss, particularly androgenetic alopecia. By blocking this receptor, setipiprant aims to inhibit the signaling pathways that contribute to hair follicle miniaturization and hair thinning. Its relevance lies in its potential to promote hair regrowth and improve hair density in individuals experiencing hair loss, distinguishing it from other treatments that may target different biological mechanisms. Ongoing clinical trials are assessing its efficacy and safety in the context of hair restoration.